SCHEMBL3263511

SCHEMBL3263511

O=C(O)CC(=O)C=CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2780997 0.77 TSHR (0.53)
SCHEMBL2780998 0.77 TSHR (0.53)
SCHEMBL1225122 0.77 TSHR (0.53)
SCHEMBL6916368 0.74
Maleylacetoacetate SCHEMBL187863 0.70 TSHR (0.45)
Maleylacetoacetate SCHEMBL187565 0.70 TSHR (0.45)
SCHEMBL9644739 0.70 LDHA (0.38)
Maleylacetoacetate SCHEMBL380205 0.70 TSHR (0.45)
SCHEMBL828197 0.69
SCHEMBL28710369 0.69 CNR2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010088408-A2 SUBUNIT SELECTIVE NMDA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS EMORY UNIVERSITY (US) 2010-08-05 WO disclosed